Nepal stands at a critical juncture, facing the imminent wave of the biodigital revolution that is rapidly transforming the global south. It is imperative that the nation seizes this moment, rather than remaining a passive observer.
Consider the profound implications for patient care: Imagine a 28-year-old woman residing in the mountainous region of Rolpa, diagnosed with cervical cancer. Her unique biological profile—encompassing genetic makeup, comprehensive medical history, daily routines, dietary habits, metabolic characteristics, gut microbiome, and the specific viral strain affecting her—represents a wealth of invaluable data, intrinsically linked to her geographical context. Currently, much of this crucial information is irretrievably lost. Envision a future where such data is readily accessible to her through a simple mobile application. Furthermore, picture this data being leveraged to develop highly personalized theranostics, offering targeted treatments for patients with similar conditions. What if the act of sharing this anonymized data could even contribute to offsetting her medical expenses? This vision underscores the transformative potential of integrated digital health solutions and positions Nepal as a burgeoning healthcare destination.
With a renewed political landscape and a government demonstrating a strong commitment to progress, Nepal is now experiencing significant interest and investment in its healthcare sector from both regional and international partners. The urgency to adopt and scale biodigital solutions is particularly pronounced as Nepal approaches its graduation from the Least Developed Countries (LDCs) category, a transition that will bring both new challenges and opportunities for cross-border healthcare and international patient care.
Advancing Digital Health Infrastructure and Addressing Implementation Gaps
Within the realm of digital health, Nepal has, encouragingly, not lagged behind its peers in developing foundational strategy papers, policies, and guidelines. We also observe promising momentum with various pilot initiatives, including community healthcare programs, telemedicine services, federal health information management systems, and the ongoing national health insurance scheme. A substantial number of the nation’s larger healthcare facilities, both governmental and private, are actively engaged in various stages of digitalization. While both indigenous and global open-source solutions have been discreetly implemented, the pressing challenge now lies in integrating these disparate systems and connecting them seamlessly with global value chains to truly enhance the quality of care. The primary hurdle, in our editorial view, is not a lack of initial drive but rather the complex execution required to achieve widespread adoption and interoperability.
In stark contrast, Nepal’s biotechnology sector remains nascent, despite the country having the same access as other LDCs to the facilitations provided under the World Trade Organisation’s Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement. Although approximately half of the domestic demand for generic pharmaceuticals is met locally, this largely depends on the bulk importation of active pharmaceutical ingredients, with concerns often raised regarding their quality. This situation stands in sharp contrast to Bangladesh, which now satisfies nearly all its domestic pharmaceutical needs and actively exports to over 150 countries. Bangladesh has strategically ascended the biotech ladder, producing advanced pharmaceuticals such as anti-cancer drugs, monoclonal antibodies, hepatitis-C vaccines, and hormones, showcasing a clear pathway for a nation aspiring to be a significant healthcare destination.
Our current fragmented digital health initiatives, frequently funded by donor agencies with diverse agendas and subject to shifting stakeholder priorities, have inadvertently created their own set of challenges. This approach has led to considerable ‘pilot fatigue,’ where promising projects fail to scale, and critical data often resides in redundant silos. This fragmentation prevents the aggregation of data that could yield exponential benefits for policymakers in Singha Durbar or significantly improve patient care for an individual in Surkhet. For Nepal to truly emerge as a competitive healthcare destination and attract international patients, a more cohesive and integrated strategy is essential.
Furthermore, the underdeveloped pharmaceutical sector and the virtually non-existent biotechnology industry necessitate a bold, long-term strategic investment from the state itself. While international donors have been instrumental in providing soft assets, guiding Nepal towards digital health adoption as a follower, it is an undeniable truth that no donor agency can, or would, provide the harder assets required for leadership, particularly in the capital-intensive biotechnology sector. This strategic self-reliance is exemplified by Malaysia’s organic development in Penang, and Cuba’s remarkable achievements through sheer national will and sustained effort, despite persistent sanctions. These examples highlight the need for intrinsic national commitment to foster a robust global healthcare presence.
Learning from Global Leaders and Regional Opportunities
Just across the border, India presents a compelling case study with its world-class pharmaceutical and rapidly expanding biotechnology sectors, coupled with decades of leadership in software and data-driven solutions. The Ayushman Bharat Digital Mission, spearheaded by the National Health Authority as a comprehensive digital health backbone, has delivered immense public benefits. Over half of India’s vast population now possesses unique health IDs, and nearly a quarter have their health records digitally accessible, a monumental stride in patient travel and healthcare accessibility.
Estonia, a nation with a population almost 20 times smaller than Nepal’s, has successfully implemented a universal Electronic Health Record system and established a genomic biobank. These advanced infrastructures position Estonia at the forefront of digital health innovation, enabling it to export its technologies and expertise globally. Similarly, Rwanda, despite its LDC status, is now exporting its health informatics experience across Africa, demonstrating that smaller countries can indeed achieve disproportionate influence, particularly when specializing in niche solutions for global healthcare. This offers a blueprint for Nepal to consider its own unique strengths in the pursuit of becoming a medical tourism hub.
Nepal’s Vision: From Scarcity to a Biodigital Unicorn
Nepal must proactively embrace this global trend. A crucial initial step involves transforming the existing National Health Insurance ID of enrollees into a unified, nationwide Digital Health ID. This foundational identifier would enable secure registration, uploading, access, and sharing of protected health information through a federal health information exchange—an information highway poised to become the bedrock of the biodigital innovation we envision. With a robust national digital health infrastructure in place, providing secure yet comprehensive access to anonymized data, Nepal can begin to aggregate the necessary resources for world-class research in biotechnology. This strategic move would not only foster a knowledge economy but also lay the groundwork for local manufacturing, elevating Nepal’s standing as a potential healthcare destination.
Furthermore, Nepal should strategically position itself as a future Research and Development hub for India, China, and other international partners, attracting a portion of their escalating healthcare expenses. By leveraging its expert diaspora in science and technology, along with critical investment and a growing, globally oriented in-house talent pool, Nepal can become a center for cutting-edge work. This could encompass healthcare AI validation, the development of genomics and other multi-omics solutions, or pioneering new drug discovery efforts to address the increasing global burden of cancers and other non-communicable diseases. Such a focus would significantly enhance the nation’s appeal for medical tourism and patient travel.
Nepal possesses unique advantages, including its mid-sized population spread across one of the world’s most biodiverse corridors, strategically located between two of the largest demographies and economies. Moreover, the nation’s geopolitical neutrality offers partners a valuable opportunity to diversify and hedge their risks, by investing in an ecosystem that recognizes Nepal as an indispensable frontier in global healthcare.
The Bottom Line: Seizing the Biodigital Opportunity
Nepal is on the verge of missing a pivotal opportunity to join the biodigital revolution sweeping across the global south. We can no longer afford to hesitate. The new government’s initiative to establish a national patient portal represents a commendable first step toward positioning Nepal for success in digital health. However, this alone is insufficient. It is imperative that we integrate biotechnology and digital health solutions to offer distinctive biodigital services, thereby enhancing our appeal as a quality healthcare destination.
For too long, Nepal has been a passive recipient of biodigital solutions, failing to recognize its intrinsic capacity to innovate and build its own. The time has come to fundamentally alter this narrative. The immense trove of health information, readily available and waiting to be harnessed from each citizen and utilized for the collective benefit, inherently embodies a democratic ethos—of the people, by the people, and for the people—paving the way for a vibrant future in medical tourism and international patient care.
The news signal for this article was referred from: https://kathmandupost.com/columns/2026/04/24/from-scarcity-to-scale-nepal-s-bid-to-become-global-south-s-healthcare-disruptor-1776995591